banner
LightNews LightNews
themedicalletter.bsky.social
The Medical Letter
@themedicalletter.bsky.social
21 followers 25 following 170 posts
A nonprofit organization that has provided independent reviews of drugs and therapeutics since 1959. Funded solely by subscriptions and donations. Because the source matters.
Posts Media Videos Starter Packs
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 2d
Free article: Antiviral Drugs for Seasonal Influenza for 2025-2026 bit.ly/3WtU6tT

#Antiviral #Flu #FOAMed
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 3d
Read our latest issue: bit.ly/3KTVjrC

#Antiviral #AlopeciaAreata #BladderCancer
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 4d
Answer: b
Meloxicam has COX-2 selectivity in vitro, which decreases at higher dosages; it has been associated with lower rates of some GI-related adverse effects than nonselective NSAIDs, and it is less likely to inhibit platelet function.
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 4d
It’s Trivia Tuesday! This question is from our article IV Meloxicam Returns for Treatment of Pain bit.ly/4n9KoaT
1
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 11d
Answer: d
Vaccination against influenza should continue to be offered as long as influenza viruses are circulating in the community. Vaccination in July or August may result in suboptimal immunity before the end of the influenza season, especially in adults ≥65 years old.
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 11d
It’s Trivia Tuesday! This question is from our article Influenza Vaccines for 2025-2026 bit.ly/4n4Dxj2
1
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 12d
Delgocitinib Cream (Anzupgo) for Chronic Hand Eczema - Read our free open-access article: medicalletter.org/anzup739b

#FOAMed
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 17d
Semaglutide (Wegovy) for MASH bit.ly/4pPQlw7
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 18d
October is American Pharmacists Month! This month we celebrate the most accessible health care providers.

#APhM2025 #PharmacistsMonth #indispensable
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 18d
Read our latest issue: bit.ly/3IMMIX7

#MASH #handeczema #depression #vaccines
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 18d
It’s Trivia Tuesday! This question is from our article Inclisiran (Leqvio) Monotherapy for LDL-Cholesterol Reduction bit.ly/3Kudggb

Answer: d
Diarrhea, bronchitis, and extremity pain have also been reported.
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 23d
Today we celebrate #WorldPharmacistDay and the vital role pharmacists play as trusted drug experts and healthcare professionals.
#ThinkHealthThinkPharmacist
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 25d
Advance Release Article: COVID-19 Update: 2025-2026 Vaccine Formulations and Recommendations bit.ly/3KC8ehF

#COVID #COVIDvaccine
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 25d
Answer: a
Acoltremon is an agonist of TRPM8 thermoreceptors. Its activity at these thermoreceptors stimulates corneal sensory nerves, increasing basal tear production.
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 25d
It’s Trivia Tuesday! This question is from our article Acoltremon (Tryptyr) for Dry Eye Disease bit.ly/3Vwc6TL
1
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 25d
Dordaviprone (Modeyso) for Diffuse Midline Glioma bit.ly/4mtzHzi
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · 27d
IV Meloxicam Returns for Treatment of Pain bit.ly/3Kf1INV
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · Sep 18
Influenza Vaccines for 2025-2026 bit.ly/4nfcL8k
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · Sep 16
It’s Trivia Tuesday! This question is from our article Drugs for ADHD bit.ly/3KfJD1W

7. Answer: d
Stimulants are preferred for treatment of ADHD in most patients. Addition of a nonstimulant may be beneficial for those who have had an inadequate response to a stimulant.
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · Sep 14
Sunvozertinib (Zegfrovy) for NSCLC bit.ly/4phZeOP
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · Sep 11
Embryotoxicity REMS Removal for Endothelin Receptor Antagonists
bit.ly/4mh4IXp
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · Sep 10
Ceftobiprole Medocaril (Zevtera) — A New Cephalosporin Antibiotic bit.ly/4gjWoEL
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · Sep 9
Inclisiran (Leqvio) Monotherapy for LDL-Cholesterol Reduction bit.ly/4gfaCHb
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · Sep 9
It’s Trivia Tuesday! This question is from our article Drugs for ADHD bit.ly/3KfJD1W

Answer: b
Stimulants are the drugs of choice for treatment of ADHD in school-age children, adolescents, and adults. Some patients may respond better to amphetamines than to methylphenidate and vice versa.
themedicalletter.bsky.social
The Medical Letter @themedicalletter.bsky.social · Sep 4
Acoltremon (Tryptyr) for Dry Eye Disease bit.ly/4nf6KrK